Literature DB >> 15385047

Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.

E C Rodriguez-Merchan1, A Rocino, B Ewenstein, L Bartha, A Batorova, J Goudemand, A Gringeri, M Joao-Diniz, S Lopaciuk, C Negrier, M Quintana, G Tagariello, G E Tjonnfjord, V A Villar, Z Vorlova.   

Abstract

Summary. Participants in an international workshop on surgery in haemophilia patients with inhibitors developed a consensus summary of the findings and conclusions of the meeting. In the consensus, participants agreed upon revised definitions for minor and major surgery, including an intermediate degree of surgery. An evaluation system of intraoperative and postoperative bleeding was developed. Recommended doses of FEIBA((R)) and rFVIIa (both in bolus injections and in continuous infusion) for surgery were agreed. Participants also agreed on the main blood tests to be performed peri-operatively. They also suggested the need of a prospective evaluation in the future. Finally, the approximate number of surgical procedures and costs performed on haemophilia patients with inhibitors were analysed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385047     DOI: 10.1111/j.1365-2516.2004.00941.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  11 in total

1.  Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate.

Authors:  Ezio Zanon; Barbara Brandolin; Graziella Saggiorato; Christian Bacci
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

Review 2.  Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.

Authors:  Amy D Shapiro; Ulla Hedner
Journal:  Ther Adv Drug Saf       Date:  2011-10

3.  Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.

Authors:  Y Dargaud; A Pavlova; S Lacroix-Desmazes; K Fischer; M Soucie; S Claeyssens; D W Scott; R d'Oiron; G Lavigne-Lissalde; G Kenet; C Escuriola Ettingshausen; A Borel-Derlon; T Lambert; G Pasta; C Négrier
Journal:  Haemophilia       Date:  2016-01       Impact factor: 4.287

4.  A case of acquired hemophilia A with massive hemothorax.

Authors:  Tomihiro Fukushima; Takeshi Mikane; Daisuke Ono; Satoru Oku; Hiroyuki Kobayashi; Yoko Watanabe; Etsu Iwasaki; Mizue Ishii; Hiroaki Tokioka
Journal:  J Anesth       Date:  2011-11-16       Impact factor: 2.078

Review 5.  The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2017-05-16       Impact factor: 3.443

Review 6.  Orthopedic disorders of the knee in hemophilia: A current concept review.

Authors:  E Carlos Rodriguez-Merchan; Leonard A Valentino
Journal:  World J Orthop       Date:  2016-06-18

7.  Declining trends in invasive orthopedic interventions for people with hemophilia enrolled in the Universal Data Collection program (2000-2010).

Authors:  P Tobase; H Lane; A-E-A Siddiqi; R Ingram-Rich; R S Ward
Journal:  Haemophilia       Date:  2016-03-31       Impact factor: 4.287

8.  Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors.

Authors:  Ampaiwan Chuansumrit; Pantep Angchaisuksiri; Nongnuch Sirachainan
Journal:  J Blood Med       Date:  2010-03-30

Review 9.  Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients.

Authors:  Heng Joo Ng; Lai Heng Lee
Journal:  Vasc Health Risk Manag       Date:  2006

10.  Barriers and perceived limitations to early treatment of hemophilia.

Authors:  Kapil Saxena
Journal:  J Blood Med       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.